Replies to post #206930 on Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

If my words speak for themselves, then you shouldn’t have a problem posting all of them instead of cherrypicking.

To answer your question, of course it’s a fail. Not meeting primary endpoints is universally considered failing a trial. People can spin otherwise according to their book.

I agree the fda and pharma matter. If ipix fails to meet primary endpoints, the fda woukd not permit ipix to run a phase 3. Pharma would not give ipix a good deal.

Case closed.